Nicolas Saglio — MsC

Chief Executive Officer 

Nicolas brings 20 years of experience in advising and investing in technology and entrepreneurial companies with expertise in entrepreneurial innovation, healthcare, technology and fintech.

Currently Founder & Managing Partner at HealthTech180 where he provides strategy advisory services, funding and innovation solutions for technology & healthcare companies. Nicolas is also currently CEO at Hemostatics, a healthcare startup which develops a novel anti-hemorrhagic drug.

Previously Partner at SkyPath Capital Partners, an innovation focused strategy advisory firm and private investment boutique focused on growth and funding strategy for technology and technology enabled industries.

Vast global network of investors ranging from HNWs, Family offices and VCs with completed investments and advisory of multiple Global M&A transactions.

Previous experience includes M&A Advisory and Principal Investing at Macquarie Bank and M&A Investment Banking Associate at Citi (SSSB).